US87164U4094 - Common Stock
THERIVA BIOLOGICS INC
NYSEARCA:TOVX (5/9/2024, 4:23:36 PM)
After market: 0.41 +0.01 (+2.5%)0.4
-0.02 (-4.53%)
Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. The company is headquartered in Rockville, Maryland and currently employs 21 full-time employees. The firm is advancing a new oncolytic adenovirus platform designed for intravenous (IV), intravitreal and antitumoral delivery to trigger tumor cell death, improve access of co-administered cancer therapies to the tumor, and promote a robust and sustained anti-tumor response by the patients immune system. The Company’s lead candidates are: VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier; SYN-004 (ribaxamase) which is designed to degrade used IV beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent microbiome damage, and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat both local GI and systemic diseases.
THERIVA BIOLOGICS INC
9605 Medical Center Drive, Suite 270
Rockville MARYLAND
P: 17343327800
Employees: 21
Website: https://therivabio.com/
- Se han presentado datos de primera línea del ensayo de fase 1 patrocinado por investigadores del VCN-01 por vía intravítrea en pacientes pediátricos con...
TOVX stock results show that Theriva Biologics beat analyst estimates for earnings per share the first quarter of 2024.
- Reported topline data from the investigator sponsored Phase 1 trial of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma; trial...
ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics...
ROCKVILLE, Maryland, April 25, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada de fase clínica que...
–Phase 1 trial in collaboration with Sant Joan de Déu-Barcelona Children’s Hospital (SJD) determined to have a positive outcome by the study Monitoring...
Here you can normally see the latest stock twits on TOVX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: